Abstract
Falsified and substandard (SF) medications are a large and growing global public health threat affecting developed and developing markets. The need for scalable, easy-to-use, accurate methods to detect SF medications continues to grow. We conducted a proof-of-principle laboratory and field sample evaluation of MedSnap in Vientiane, Lao PDR. Over three days, MedSnap models were created from trusted and authentic medications and tested against samples of authentic/trusted or falsified artesunate, artemether-lumefantrine, azithromycin, and ciprofloxacin. Across 48 tests of authentic/trusted and falsified samples, MedSnap was 100% sensitive and specific. On the final day of the study, a convenience sample of ciprofloxacin and azithromycin was collected from local pharmacies and tested. Each field sample matched an authentic/trusted model. The speed and ease of data collection, reference model building, and sample testing suggest scalable use cases for the system.
Competing Interest Statement
The authors are employed full time with Indicator Sciences. Drs. Hymel and Brossette are the owners of Indicator Sciences. Indicator Sciences received only travel and hardware expense reimbursement for this work.
Funding Statement
This project is supported by the Fleming Fund, a UK aid programme from the UK's Department of Health and Social Care (www.flemingfund.org) Indicator Sciences received only travel and hardware expense reimbursement for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No patients or patient data were involved in this study, so IRB or other oversight approval was not necessary.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available from the corresponding author, upon reasonable request.
